A Novel Validated Stability Indicating Chromatographic Method for the Simultaneous Estimation of Ascorbic acid and Gallic acid in the Ayurvedic Capsule Dosage form of Amla by UFLC

 

Hima V.*, Rubesh Kumar S., Duganath N., Devanna N.

Department of Pharmaceutical Analysis, JNTUA - Oil Technological Research Institute, Anantapur, Andhra Pradesh, India.

*Corresponding Author E-mail: himavallapudas@gmail.com

 

ABSTRACT:

An Ultra Fast liquid chromatographic method has been developed and validated for simultaneous estimation of ascorbic and gallic acid in both API and Ayurvedic formulation. Chromatographic separation of compounds was carried out with C8 column by using a mobile phase of methanol: phosphate buffer, PH 3.0 (1: 5) at a flow rate of 1.0 ml/ min. UV detection was performed using PDA detectors at 264 nm. The method was validated for accuracy, precision, linearity, LOD, LOQ and robustness in accordance with ICH guidelines. Amounts of ascorbic and gallic acid detected in capsule were 99.20% and 99.45%. Total run time was below 3 min, ascorbic and gallic acid was eluted with retention times of 1.541 and 2.591 min respectively. Validation revealed that the method is specific, accurate, precise, reliable and reproducible. Calibration plots were linear over the concentration ranges 1–9 μg/ ml for ascorbic acid and for gallic acid, respectively. Limits of detection were 0.0382 and 0.14811 μg/ ml and limits of quantification were 0.1159 and 0.4488 μg/ml for ascorbic and gallic acid, respectively. Recovery was 99.60 – 100.28% and 100.26 -101.35% for ascorbic and gallic acid, respectively. The stress degradation studies were performed for both API and Ayurvedic as per ICH guidelines, the degradation was observed in oxidative, photolytic, hydrolytic degradation under acidic, alkaline conditions and dry heat induced studies.  The proposed method is rapid, simple and also it can be applied for the routine analysis of herbal formulations.

 

KEYWORDS: Ascorbic acid, gallic acid, UFLC, Stress degradation studies.

 

 


INTRODUCTION:

Amla (syn: Emblica officinal’s, Emblica Myrobalan, Phyllanthus Emblica) also known as Indian gooseberry. It is a deciduous tree of the family belong to family Euphorbiaceae1 and this species is native to India and also grows in tropical and subtropical regions including Pakistan, Srilanka, South East Asia, China and Malaysia.

 

The fruits of Emblica officinals are widely used in the Ayurveda2 and are believed to defence against diseases. Different types of gooseberry species are present world widely, those are  Pereskia aculeate  (syn: Barbados gooseberry) belongs to family Cactaceae and it  is native to tropical America, Physalis peruviana (syn: cape goose berry ) belongs to family Solanaceae and it is  native to South Africa, Dovyalis hebecarpa (syn: Ceylon gooseberry) belongs to family  Flacourtiaceae and it is native to Sri Lanka and southern India, Kiwifruit  (syn: Chinese goose berry) belongs to family Actinidiaceace and it  is native to New Zealand, Italy, Chile, Greece and france, Phyllanthus acidus (syn: star gooseberry) belongs to family  Phyllanthaceae and it is  native to South East Asian countries, Ribes grossularia (syn: European berry)  belongs to family Grossulariaceae and it is native to Europe east to the Caucasus and south to North Africa, Ribes hirtellum(syn: American goose berry) belongs to family Melastomaceae and it is  native to Northern America.

Emblica officinal’s primarily contains tannins (gallic acid, ellagic acid) 3, 1-O-galloyl-beta-D-glucose, 3,6-di-O-galloyl-Dglucose, chebulinic acid, quercetin, alkaloids, phenolic compounds, amino acids and carbohydrates4, chebulagic acid. Its fruit juice contains the highest vitamin C. The principal constituents of ascorbic acid and gallic acid are shown in Fig. 1, 2.

 

Figure1: Structure of Ascorbic acid 

Mol Formula - C6H8O6   

Mol Wt - 176.12 g mol-      

 

Figure2: Structure of Gallic acid                    

Mol Formula – C7H6O5  

Mol Wt - 170.12 g mol-             

 

Vitamin C or ascorbic acid is a water-soluble nutrient and it can be extracted from various fruits and vegetables 5i.e. Amla, parsley, broccoli, bell peppers, strawberries, oranges, lemon juice, papaya, cauliflower, kale, mustard greens and Brussels sprouts. The following pharmacological actions has been reported for vitamin c which includes anti-diabetic, anti-oxidant6, anti-tumour, anti-plasmodial, anti-inflammatory, anti-microbial7 anti-rheumatic and also possess hepatoprotectivity .Vitamin C was also used for preventing and treating scurvy, common cold, it is applied to the skin to help with damage from radiation therapy8.

                              

Gallic acid is a phenolic compound exists in plant material in the form of free acids, esters, catechin derivatives and hydrolysable tannins9, 10.  The interest in this compound is due to its pharmacological activity as radical scavengers. It has been proved to have potential preventive and therapeutic effects in many diseases, where the oxidative stress has been implicated, including cardiovascular diseases, antioxidant10, antimicrobial, antiviral, anticarcinogenic11, radio protective neurodegenerative disorders and anti purgative.

 

The objective of the present investigation was to establish and validate the fast and sensitive ultra fast liquid chromatography (UFLC) method for determination of ascorbic acid and gallic acid in ayurvedic formulation.

 

EXPERIMENTAL WORK:

Apparatus:

The UFLC system Shimadzu SP 20 AD equipped with 20μl loop and PDA Detector. Integration was achieved by using the software LC solutions which was utilized for instrument control, data collection and data processing. Separation was carried out on a prepacked symmetry, 350µm, 4.6 x 150mm C8 column with a vacuum degasser.

 

Reagents and materials:

The drug samples such as Ascorbic acid from SDFCL (SD Fine Chem Limited) and Gallic acid from (Sigma life sciences) were purchased.  Potassium dihydrogen phosphate (SDFCL (SD Fine Chem Limited), Triethylamine (SDFCL (SD Fine Chem Limited), MilliQ water (Merck), Methanol (Merck). All chemicals and solvents used were of GR/HPLC grade, chemicals such as Hydrogen peroxide (SDFCL (SD Fine Chem Limited), Sodium Hydroxide (Mio Chem Pvt. Ltd), and Hydrochloric acid (Merck Chemicals) were of analytical grade dissolved in MilliQ water used for stress degradation studies. Amla capsule (The Rising Pharmaceuticals) with 500 mg of label claim obtained from local drug store.

 

Chromatographic Conditions:

The mobile phase is a mixture of methanol and Phosphate buffer. The pH of the buffer is maintained at 3.0 with 0.1N hydrochloric acid. The prepared buffer was filtered through a Millipore 0.45μm membrane filter and ultrasonically degassed prior to use. Methanol and Phosphate buffer used in the ratio of 1:5 (v/v) throughout the experiment. The detection wavelength was set at 264 nm. The elution was done at a flow rate of 1.0 ml/min under ambient condition.

 

Preparation of standard solutions:

Accurately weighed quantity of 10mg of ascorbic acid and 10mg of gallic acid were added into a 10 ml separate volumetric flasks and dissolved under sonication by 5ml of diluent, the volume was made by diluent and mixed well. Then the solutions were filtered through 0.45µ membrane filter and the final concentration of the resulting solutions was 1mg/ml. Further dilutions were made from the std stock solutions.

 

Preparation of sample:

20 capsules were taken and made into fine powder. Powder equivalent to about 500mg was taken into a 100ml volumetric flask and about 70ml of diluent was added and dissolved by sonication, and the volume was made up with mobile phase and mixed well. The solution was filtered through 0.45µ membrane filter. Final concentration of the resulting solution was 1mg/ml.

 

Procedure:

Separate and filtered portions of equal volume of (about 20µl) of standard preparations and assay preparation were injected into the system and the chromatogram was recorded shown in fig 3, 4, 5 and the peak responses of the major peak were measured.

 

Fig 3: chromatogram of Ascorbic acid

Fig 4: Chromatogram of Gallic acid

Fig 5: Chromatogram of sample (Amla Ayurvedic capsule)

 

Method Validation:

The UFLC method was validated for specificity, linearity, accuracy, precision, limit of detection, limit of quantization and robustness for the analysis of ascorbic acid and gallic acid. All validation studies were performed as per guidelines of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) 12-14.

 

Specificity:

Specificity was assessed by comparing the chromatograms obtained from sample and from the standards shown in Figure. The method was found to be specific from the peak purity of analytes and no interference of other constituents with the eluting peaks and also by comparing the retention times of both standard solutions and sample which were identical, hence method was specific for quantitative estimation of both drugs in the ayurvedic formulation.

 

Linearity:

The linearity was determined separately for ascorbic and gallic acid. Solutions of the standards at different concentrations were analyzed and calibration curves were constructed by plotting mean areas against the respective concentrations. The method was evaluated by determination of the correlation coefficient and intercept values (Table 1, 2). From the calibration plots it was clear that the linear range for ascorbic acid and gallic acid was between             1 - 9μg/ml.

 

Accuracy:

The accuracy of the method is the closeness of the measured value to the true value; Accuracy was assessed by determination of the recovery of the method by addition of standard drug to pre-analyzed test sample preparation at 3 different concentration levels 80, 100 and 120 %, taking into consideration percentage purity of added bulk drug samples. Each concentration was chromatographed 3 times and average recoveries were measured. The recovery of all these related substances were found to be in between the predefined acceptance criterion of ascorbic acid and gallic acid were found to be 98.60–100.28% and 100.26– 101.35% respectively, and the data is given in Table 3, 4.

 

Precision:

The closeness of agreement between a series of measurements obtained from multiple samplings of the same homogeneous sample.

 

Here the precision was established by using two methods:

a) Method Precision:

The repeatability of the method was established by estimating the assay for six different sample preparations of the same batch and the data is given in Table 5.

 

b) Intermediate Precision (Ruggedness):

Intraday Precision:

The intraday precision of the method was established by estimating the assay of ascorbic acid and gallic acid for six different standard preparations of the same batch by different analysts on a same day and the data is given in Table 6.

 

Interday Precision:

The interday precision of the method was established by estimating the assay of ascorbic acid and gallic acid for six different standard preparations of the same batch by different analysts on a different day and the data is given in Table 6.

 

c) System Precision:

The system precision of the method was established by estimating the assay for six different standard preparations of the same batch and the data is given in Table 7.

 

LOD and LOQ:

In the present study, the LOD and LOQ were calculated according to the 3.3σ/S and 10σ/S criterions, respectively; where σ is the standard deviation of y-intercepts of regression lines and s is the slope of the calibration curve.

 

The limits of detection and quantification of the method were studied to detect the lowest amount of analyte and quantitative determination of analyte in a sample respectively. The results are reported in Table 8.

 

Robustness:

The robustness of the method was evaluated by assaying test solutions after slight but deliberate changes in the analytical conditions. For the proposed method it was done by injecting system suitability preparation into UFLC system with 0.9 ml/min and 1.1 ml/min and also by changing the wavelength i.e. (262nm and 266nm) to get the robustness of the assay method. The results are reported in Table 9.

 

System suitability:

System suitability was defined as the evaluation of system, analytical operations and samples. A system suitability experiment was performed before determination of ascorbic and Gallic acid in sample.  Six replicate injections of standard preparation were injected and resolution, repeatability, number of theoretical plates and tailing factor were determined. The results are reported in Table 10.

STRESS DEGRADATION STUDIES:

The stress degradation studies such as hydrolytic (in acidic and alkali medium), photolytic, oxidative and dry heat induced degradation studies were performed for API and marketed Ayurvedic formulation as per ICH guidelines 15Q1A (R2). The results are reported in Table 11.

 

1. Hydrolytic degradation under acidic conditions:

Hydrolytic degradation studies were performed by taking 0.05g of drug in 50ml of 0.1N methanolic hydrochloric acid and it was refluxed in round bottomed flask on boiling water bath for 8hrs.  The remaining s was kept at room temperature.

 

 

2. Hydrolytic degradation under alkaline condition:

Hydrolytic degradation studies were performed by taking 0.05g of drug in 50ml of 0.1N methanolic sodium hydroxide and it was refluxed in round bottomed flask on boiling water bath for 8hrs.  The remaining was kept at room temperature.

 

3. Oxidative degradation:

Oxidative degradation studies were performed by taking 0.05g of drug in 50ml of 3%hydrogen peroxide and it was refluxed in round bottomed flask on boiling water bath for 8hrs.  The remaining was kept at room temperature.

 

4. Dry heat induced degradation:

Dry heat induced degradation study was performed by taking 0.01g of drug in different weighing bottles were kept at 70oC and 25oC for different time intervals i.e.,7,14,30 days.

 

5. Photolytic degradation: 

A photolytic degradation study was performed by exposing 0.01g of drug is evenly spread in a Petri dish and kept in sun light and also blank in dark condition for different time intervals i.e.,7,14,30 days.

 

RESULTS AND DISCUSSION:

 

Fig 6: Linearity graph of Ascorbic acid

 

Fig 7: Linearity graph of Gallic acid

Table 1: Linearity results of ascorbic acid:

S.No

Concentration (µg/ml)

Area

1

1

905174

2

2

1542690

3

3

2185476

4

4

2854186

5

5

3506874

6

6

4125862

7

7

4752811

8

8

5377934

9

9

5987532

 

Table 2: Linearity results of gallic acid

S.no

Concentration (µg/ml)

Area

1

1

365895

2

2

665892

3

3

964858

4

4

1264897

5

5

1568120

6

6

1836858

7

7

2136845

8

8

2435891

9

9

2698473

 


Table 3: Accuracy results of Ascorbic acid:

Spike level

Area

Amount added (mg)

Amount recovered (mg)

% Recovered

Mean Recovery

%RSD

80%

571684

792

781.54

 

98.60

0.24

569689

792

778.84

98.33

572416

792

782.57

98.80

100%

911938

990

996.80

100.68

100.28

0.48

917524

990

1003.50

101.36

908825

990

993.99

100.40

120%

1286581

1188

1172.6

98.70

99.78

1.41

1321568

1188

1204.51

101.38

1293829

1188

1179.23

99.26

 

Table 4: Accuracy results of Gallic acid:

Spike level

Area

Amount  added(mg)

Amount  recovered (mg)

% Recovered

Mean  Recovery

  %RSD

80%

239689

792

810.65

102.35

101.35

0.85

236581

792

 800.14

101.02

235863

792

797.71

100.70

100%

372953

990

1009.09

101.92

101.37

0.46

 

371524

990

1005.2

101.53

369485

990

999.71

100.98

120%

528369

1188

1191.33

100.28

100.26

0.24

526943

1188

1188.12

100.01

529475

1188

1193.83

100.49

 

Table 5: Method precision results of Ascorbic acid and Gallic acid:

SS.no

Retention time (min)

Area

Gallic acid

Ascorbic  acid

Gallic acid

Ascorbic  acid

1

2.612        

1.527

382769

915862

2

2.610

1.527

388571

913587

3

2.608       

1.522

386586

916824

4

2.620         

1.533

385821

904587

5

2.594        

1.522

388746

918751

6

2.581          

1.522

381268

917536

 

 

 

Mean = 385626.8

Mean = 914524.5

 

 

 

S.D =3050.3

S.D = 5169.949

 

 

 

%RSD =0.79

%RSD = 0.56

 

Table 6: Ruggedness results of Ascorbic acid and Gallic acid:

 

Compound

Rt(min)

Mean area

%RSD

Intraday precision

Ascorbic acid

6.826

909623

0.61

Gallic acid

2.413

377029

1.63

Interday precision

Ascorbic acid

1.540

944174.5

0.23

Gallic acid

2.5857

384715.5

0.78

 

Table 7: System precision results of Ascorbic acid and Gallic acid:

S. No

Retention time (min)

Area

Gallic acid                     Ascorbic acid

Gallic acid                                         Ascorbic  acid

1

2.582

1.574

368217

927584

 

2.591

1.549

371472

925874

 

2.595

1.542

368726

908726

 

2.598

1.541

368293

917452

 

2.582

1.538

378242

915863

 

2.591

0.536

368934

924767

 

 

 

Mean =  370647.3

Mean =920044.3

 

 

 

S.D =3909.871

 S.D =7286.2

 

 

 

 %RSD  = 1.05

%RSD=0.79

 

Table 8: LOD and LOQ of Ascorbic acid and Gallic acid:

Compound

LOD(µg/ml)

LOQ(µg/ml)

Ascorbic acid

0.03820

0.1159

Gallic acid

 0.14811

 0.4488

 

Table 9:  Robustness results of Ascorbic acid and Gallic acid:

ASCORBIC ACID

GALLIC ACID

Parameter Modifications

Plate count

Tailing

Rt (min)

Plate count

Tailing

Rt (min)

Flow Rate (ml/min)

0.9

16360

1.475

1.602

33176

1.322

2.742

1.1

15171

1.506

1.516

30624

1.329

2.589

Detection wavelength(nm)

262

15860

1.554

1.575

31802

1.316

2.715

266

15282

1.601

1.568

31347

1.311

2.699

 

Table 10:  System suitability parameters of Ascorbic acid

S. no

Retention time(min)

Peak area

Theoretical plates

Tailing

1

1.527

915862

20405.346 

1.893

2

1.527

913587

17774.411

1.632

3

1.522

916824

17306.976 

1.624

4

1.533

904587

18622.976

1.618

5

1.522

918751

18609.311 

1.634

6

1.522

917536

18732.719 

1.710

 

Table10: System suitability parameters of Gallic acid

S.no

Retention time(min)

Peak area

Theoretical plates

Tailing

Resolution

1

2.612        

382769

33140.521

1.386

7.636

2

2.610       

388571

28985.323

1.336

7.873

3

2.608       

386586

28278.573

1.354

7.773

4

2.620        

385821

29195.173

1.375

7.932

5

2.594        

388746

29482.749

1.366

7.945

6

2.581          

381268

29085.517

1.399

7.968

 

Table 11: Stress degradation studies of ascorbic acid and gallic acid

S.NO

Stress degrdation studies

Time  period

Ascorbic  acid

Gallic  acid

1

Hydrolytic degradation under acidic conditions

1hr

Degradation   was Observed

Degradation   was Observed

2

Hydrolytic degradation under alkali conditions

1hr

Degradation   was Observed

Degradation    was Observed

3

Photolytic degradation

1hr

Degradation   was Observed

Degradation    was Observed

4

Oxidative degradation

1 day

Degradation   was Observed

Degradation    was Observed

5

Dry   heat    induced degradation

 1 day

Degradation    was Observed

Degradation    was Observed

 


CONCLUSION:

The present work revealed that this developed method was simple, efficient, reliable and cost effective for the quantization of ascorbic acid and gallic acid in herbal formulation. Moreover, the lower solvent consumption along with the short analytical run time of 3 minutes that allows the analysis of a large number of samples in a short period of time. With the growing demand for herbal drugs and with increased belief in the usage of herbal medicine, this standardization tool will help in maintaining the quality of this important Ayurvedic preparation.

 

REFERENCES:

1.       Mirunalini. Sankaran, Vaithiyanathan. Velusamy, Mani. Krishnaveni.  A Novel Ayurvedic Herb as a functional food for health benefits. International Journal of Pharmacy and Pharmaceutical Sciences.5 (1); 2013: 1- 4.

2.       Government  of  India,  Ministry  of  health  and  family  welfare, The  Ayurvedic  pharmacopeia of India Vol I, Department of ayush, 7.

3.       K.P. Srivasuki. Nutritional and Health Care Benefits of Amla. Journal of Pharmacognosy.3 (2); 2012: 147-151.

4.       M. Suriyavathana, P. Subha Proximate. Proximate analysis on biochemical study of Phyllanthus acidus, Phyllanthus emblica and Citrus limon .International Journal of Pharmacy and Life Sciences.2 (6); 2011: 801-804.

5.       M.M. Rahman Khan, M.S. Rahman, Islam, S.A. Begum. UV-spectrophotometric Method for the Determination of Vitamin C Content in Various Fruits and Vegetables at Sylhet Area in Bangladesh. Journal of Biological Sciences.6; 2006: 388-392.

6.       Weerasak Samee1 eta al. Correlation Analysis between Total Acid, Total Phenolic and Ascorbic Acid Contents in Fruit Extracts and Their Antioxidant Activities Thai Pharm Health Sci J.3(6); 2006 :196-203.

7.       Gurav. Nilesh et al. Physicochemical and antimicrobial activity of single herbal formulation capsule containing Emblica officinalis Gaertn. International Journal of    Pharmacy and Pharmaceutical Sciences. 3(5); 2011: 383-386.

8.       K.H. Khan. Roles of Emblica officinalis in Medicine - A Review. Botany Research International. 2(4); 2009: 218-228.               

9.       Rajasekaran.A, Arivukkarasu.R, Archana.D. HPTLC Method for estimation of Gallic acid and Rutin in Haritaki -An Ayurvedic Formulation. International Journal of PharmTech Research. 3(2); 2011: 986-999.       

10.     Dr. Ravindra Sharma. .Medicinal plants of India-An encyclopedia. 4.  2003.

11.     Sharma P.C, Yelne M.B, Dennis T.J.  Database on Medicinal plants used in Ayurveda. Central council for Research in Ayurveda and Siddha .1; 2000: 57-64.

12.     Jose JK, Kuttan G, George J and Kuttan R.  Antitumour activity of Emblica officinalis. Journal of Clinical Biochem Nutrition. 75(2); 2001: 65-69.

13.     ICH Guideline Q2 (R1). Validation of analytical procedures: text and methodology. November.2005.

14.     Validation of Analytical Procedures: Methodology (Q2B). ICH Harmonized. Tripartite Guidelines, Geneva. 1996.

15.    ICH Guideline Q1A (R2).  Stability Testing of New Dosage Forms, February.  2003.

 

 

 

Received on 05.07.2013       Modified on 18.07.2013

Accepted on 21.07.2013      © AJRC All right reserved

Asian J. Research Chem. 6(9): September 2013; Page   826-831